Intussusception following rotavirus vaccination: An updated review of the available evidence

Expert Review of Vaccines

Volumn 13, Issue 11, 2014, Pages 1339-1348

  Rha, Brian ^a,b   Tate, Jacqueline E ^a   Weintraub, Eric ^c   Haber, Penina ^c   Yen, Catherine ^a   Patel, Manish ^a   Cortese, Margaret M ^a   Destefano, Frank ^c   Parashar, Umesh D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

intussusception; rotavirus; rotavirus disease; rotavirus vaccine; safety; vaccines

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE;

AUSTRALIA; BRAZIL; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; HUMAN; INTUSSUSCEPTION; MEXICO; REVIEW; UNITED STATES; VACCINATION; ADVERSE EFFECTS; CHEMICALLY INDUCED;

HUMANS; INTUSSUSCEPTION; ROTAVIRUS VACCINES; UNITED STATES; VACCINATION; VACCINES, ATTENUATED;

EID: 84911489587     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2014.942223     Document Type: Review

References (53)

1. Bines JE, Kohl KS, Forster J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22(5-6):569-74
2. WHO. Acute intussusception in infants and children. incidence, clinical presentation and management: a global perspective. WHO; Geneva: 2002. 1-98
3. Jiang J, Jiang B, Parashar U, et al. Childhood intussusception: a literature review. PLoS One 2013;8(7):e68482
4. Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12(2):136-41
5. Bines JE, Liem NT, Justice FA, et al. Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated, but not rotavirus. J Pediatr 2006;149(4):452-60
6. Rennels MB, Parashar UD, Holman RC, et al. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J 1998;17(10):924-5
7. Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J 2002;21(2):97-102
8. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999;48(43):1007
9. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354(1):23-33
10. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354(1):11-22
11. Patel MM, Haber P, Baggs J, et al. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccines 2009;8(11):1555-64
12. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recomm Rep 1999; 48(RR-2):1-20
13. Joensuu J, Koskenniemi E, Vesikari T. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Pediatr Infect Dis J 1998;17(4):334-40
14. Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine-United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999;48(27):577-81
15. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001;344(8):564-72
16. Kramarz P, France EK, Destefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J 2001;20(4):410-16
17. Peter G, Myers MG; National Vaccine Advisory Committee, National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 2002;110(6):e67
18. WHO. Report of the meeting on future directions for rotavirus vaccine research in developing countries: Geneva, 9-11 February 2000. WHO, World Health Organization; Geneva: 2000. 1-56
19. Simonsen L, Viboud C, Elixhauser A, et al. More on rotashield and intussusception: the role of age at the time of vaccination. J Infect Dis 2005;192(Suppl 1):S36-43
20. Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis 2006; 193(6):898; author reply 898-9
21. Gargiullo PM, Murphy TV, Davis RL. Is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine? J Infect Dis 2006; 194(12):1793-4.author reply 1794-5
22. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007;370(9601):1757-63
23. WHO. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009;84(51-52):533-7
24. Patel MM, Lopez-Collada VR, Bulhoes MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med 2011; 364(24):2283-92
25. Velazquez FR, Colindres RE, Grajales C, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012;31(7): 736-44
26. Buttery JP, Danchin MH, Lee KJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29(16):3061-6
27. Carlin JB, Macartney KK, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clin Infect Dis 2013;57(10):1427-34
28. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008;121(6):1206-12
29. Belongia EA, Irving SA, Shui IM, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J 2010;29(1):1-5
30. Shui IM, Baggs J, Patel M, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012;307(6):598-604
31. Zickafoose JS, Benneyworth BD, Riebschleger MP, et al. Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States. Arch Pediatr Adolescent Med 2012;166(4):350-5
32. Yen C, Tate JE, Steiner CA, et al. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009. J Infect Dis 2012;206(1):41-8
33. Eng PM, Mast TC, Loughlin J, et al. Incidence of intussusception among infants in a large commercially insured population in the United States. Pediatr Infect Dis J 2012;31(3):287-91
34. Tate JE, Simonsen L, Viboud C, et al. Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 2008;121(5):e1125-32
35. Centers for Disease C, Prevention. Addition of history of intussusception as a contraindication for rotavirus vaccination. MMWR Morb Mortal Wkly Rep 2011; 60(41):1427
36. Haber P, Patel M, Pan Y, et al. Intussusception after rotavirus vaccines reported to US VAERS, 2006-2012. Pediatrics 2013;131(6):1042-9
37. Yih WK, Lieu TA, Kulldorff M, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med 2014;370(6):503-12
38. Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med 2014; 370(6):513-19
39. Global Advisory Committee on Vaccine Safety. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations. Wkly Epidemiol Rec 2014;89(7):53-60
40. Mpabalwani EM, Chitambala P, Chibumbya JN, et al. Intussusception incidence rates in 9 zambian hospitals, 2007-2011: prerotavirus vaccine introduction. Pediatr Infect Dis J 2014; 33(Suppl 1):S94-8
41. Ngendahayo E, Bonane A, Ntakiyiruta G, et al. Preparing for safety monitoring after rotavirus vaccine implementation: a retrospective review of intussusception cases among children at a large teaching hospital in Rwanda, 2009-2012. Pediatr Infect Dis J 2014;33(Suppl 1):S99-S103
42. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010;362(4):289-98
43. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376(9741):606-14
44. Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 376(9741):615-23
45. Patel M, Shane AL, Parashar UD, et al. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009;200(Suppl 1):S39-48
46. Patel M, Steele AD, Parashar UD. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine 2012;30(Suppl 1):A30-5
47. Patel MM, Clark AD, Sanderson CF, et al. Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis. PLoS Med 2012;9(10):e1001330
48. WHO. Rotavirus vaccines WHO position paper-January 2013. Wkly Epidemiol Rec 2013;88(5):49-64
49. Rha B, Tate JE, Payne DC, et al. Effectiveness and impact of rotavirus vaccines in the United States-2006-2012. Expert Rev Vaccines 2014;13(3):365-76
50. Patel MM, Steele D, Gentsch JR, et al. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011;30(1 Suppl):S1-5
51. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011;30(1 Suppl): S56-60
52. Cortese MM. Advisory Committee on Immunization Practices Meeting Summary Report. 19-20 June 2013. Atlanta, Georgia
53. Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 2014; 383(9935):2136-43